Showing results (21-30 of 49) with videos related to
Sort By:
Pageof 5
Pharmacology, Biochemistry, and Behavior|January 1, 1994
Downregulation of rat brain cannabinoid binding sites after chronic delta 9-tetrahydrocannabinol treatmentF Rodríguez de Fonseca, M A Gorriti, J J Fernández-Ruiz, et al.Pharmacology, Biochemistry, and Behavior|March 1, 1992
Early changes in the development of dopaminergic neurotransmission after maternal exposure to cannabinoidsF Rodríguez de Fonseca, M L Hernández, R de Miguel, et al.Life Sciences|January 1, 1995
Long-term behavioral effects of perinatal exposure to delta 9-tetrahydrocannabinol in rats: possible role of pituitary-adrenal axisP Rubio, F Rodríguez de Fonseca, R M Muñoz, et al.The Journal of Pharmacology and Experimental Therapeutics|January 1, 1996
Corticotropin-releasing factor (CRF) antagonist [D-Phe12,Nle21,38,C alpha MeLeu37]CRF attenuates the acute actions of the highly potent cannabinoid receptor agonist HU-210 on defensive-withdrawal behavior in ratsF Rodríguez de Fonseca, P Rubio, F Menzaghi, et al.Pharmacology, Biochemistry, and Behavior|November 1, 1991
Effects of delta-9-tetrahydrocannabinol exposure on adrenal medullary function: evidence of an acute effect and development of tolerance in chronic treatmentsF Rodríguez de Fonseca, J J Fernández-Ruiz, L Murphy, et al.European Journal of Pharmacology|February 14, 1995
The dopamine receptor agonist 7-OH-DPAT modulates the acquisition and expression of morphine-induced place preferenceF Rodríguez De Fonseca, P Rubio, J L Martín-Calderón, et al.Journal of Neural Transmission. General Section|January 1, 1993
delta 9-Tetrahydrocannabinol affects mesolimbic dopaminergic activity in the female rat brain: interactions with estrogensA Bonnin, J J Fernández-Ruiz, M Martín, et al.Neurotoxicity Research|April 28, 2004
Role of the endogenous cannabinoid system as a modulator of dopamine transmission: implications for Parkinson's disease and schizophreniaF Rodríguez De Fonseca, M A Gorriti, A Bilbao, et al.Pharmacology, Biochemistry, and Behavior|December 18, 2010
Additive effects of cannabinoid CB1 receptors blockade and cholecystokinin on feeding inhibitionL Orio, I Crespo, J A López-Moreno, et al.Neuroimmunomodulation|December 22, 1999
Maternal exposure to the synthetic cannabinoid HU-210: effects on the endocrine and immune systems of the adult male offspringI del Arco, R Muñoz, F Rodríguez De Fonseca, et al.Pageof 5